Open AccessAnticoagulant treatment after a bleeding event: between Scila and Caribda
Author(s) -
Camelia Cristina Diaconu,
Universitatea de Medicină şi Farmacie „Carol Davila“ Bucureşti,
Sorin Hostiuc,
Mădălina Ilie,
Alice Bãlãceanu,
Clinica de Medicină Internă Spitalul Clinic de Urgenţă Floreasca
Publication year - 2015
Publication title -
romanian medical journal
Language(s) - English
Resource type - Journals
eISSN - 2069-606X
pISSN - 1220-5478
DOI - 10.37897/rmj.2015.3.14
Subject(s) - medicine , anticoagulant therapy , anticoagulant , major bleeding , event (particle physics) , intensive care medicine , surgery , atrial fibrillation , physics , quantum mechanics
Anticoagulant therapy is very important in preventing thromboembolic complications in a broad category of patients. When a bleeding event appears in anticoagulated patients, we should take into consideration the circumstances and the moment when the anticoagulant treatment should be resumed in patients who have an indication for temporary or permanent anticoagulation. This decision is often difficult. It should be weighted very carefully, on one hand, the thromboembolic risk of the patient, on the other hand the risk of recurrence of the recent bleeding event. The decision to resume the anticoagulant therapy depends also on the severity of the bleeding event, as well as the source of bleeding.